Investigational Blood Biomarker Panel May Improve Detection of Pancreatic Cancer
January 28, 2026
January 28, 2026
PHILADELPHIA, Pennsylvania, Jan. 28 [Category: Medical] -- The American Association for Cancer Research posted the following news release:
* * *
Investigational Blood Biomarker Panel May Improve Detection of Pancreatic Cancer
*
PHILADELPHIA - A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) co . . .
* * *
Investigational Blood Biomarker Panel May Improve Detection of Pancreatic Cancer
*
PHILADELPHIA - A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) co . . .
